Drug intelligence / Profile preview

aceclofenac + paracetamol (Zeebharat Med Private Limited)

Development stage
Unknown
Lead developer
Zeebharat Med Private Limited
Modality
Small Molecules
Administration
Oral
01

Overview

Aceboat P is a fixed-dose combination medication containing aceclofenac and paracetamol, developed by Zeebharat Med Private Limited. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class that acts by inhibiting the cyclooxygenase (COX) enzymes, primarily COX-2, thereby blocking the synthesis of prostaglandins involved in pain and inflammation. Paracetamol (acetaminophen) is an analgesic and antipyretic agent that works through central nervous system pathways to increase the pain threshold and reduce fever. This combination is commonly used for the management of acute and chronic pain associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Brand names
Aceboat P
Other names
Aceclofenac and Paracetamol
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)COX-3 (Prostaglandin-endoperoxide synthase 1 (Cyclooxygenase-1) CNS variant)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on aceclofenac + paracetamol (Zeebharat Med Private Limited).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceclofenac + paracetamol (Zeebharat Med Private Limited).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call